Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study. - Wikidata - awgldk - TriplyDB

Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study.

Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study.

http://www.wikidata.org/entity/Q47701176

about

Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy Minimally invasive image-guided therapies for hepatocellular carcinoma Model-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicine Locoregional treatment for hepatocellular carcinoma: The best is yet to come.Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model?Radiofrequency ablation of small hepatocellular carcinoma with intravenous pegylated liposomal doxorubicin.Liver cancer: Approaching a personalized care.Development of biodegradable radiopaque microsphere for arterial embolization-a pig study Current status of multimodal & combination therapy for hepatocellular carcinoma.Chemoembolization and radioembolization for hepatocellular carcinoma.Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead.Drug-eluting bead therapy in primary and metastatic disease of the liver.DC Bead: a major development in the toolbox for the interventional oncologist.Interventional radiological treatment of hepatocellular carcinoma.Loco-regional treatment of hepatocellular carcinoma.DC Bead embolic drug-eluting bead: clinical application in the locoregional treatment of tumours.Hepatocellular carcinoma: MR staging and therapeutic decisions.Drug delivery embolization systems: a physician's perspective.Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations Treatment of intermediate-stage hepatocellular carcinoma.Image-guided ablation of primary liver and renal tumours.New treatment modalities for hepatocellular cancer.Radiofrequency ablation combined with transcatheter therapy in rabbit VX2 liver tumors: effects and histopathological characteristics.Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology.Superselective particle embolization enhances efficacy of radiofrequency ablation: effects of particle size and sequence of action.Multimodality treatment of unresectable hepatic metastases from pancreatic glucagonoma.Radiofrequency ablation after arterial injection of miriplatin-iodized oil suspension into swine liver: ablative zone size and tissue platinum concentration.

P2860

Q26766707-041374F5-A9A8-4E13-87F9-FF73A222D7BD Q27015918-118E120E-AA9B-4907-8F19-16BD32169A05 Q28079027-2D2D2D9B-8DCC-40F7-8C8B-0369ADBF76A1 Q28087569-6D28D548-9262-46C2-AE36-3BD241774EB7 Q30400312-1F559517-8ADB-42BE-8980-749C2A317361 Q33746626-E76FFFF4-CA2E-4A16-9DCE-6EC79B66B398 Q34321360-22FD0091-6AFB-4DC1-ADE3-C1448DCF1339 Q34553541-7D396A02-04FE-4B97-B7DC-10B4B15C8488 Q35903794-02B31F20-4993-4EA9-80FF-F695A282B9EB Q36006427-5CC9A75D-1015-454A-8865-25DF14BF59CC Q36436294-A2B64476-0AAE-45F1-BC7D-1A767B371C91 Q37238192-2749CCD1-2DB4-474D-A895-63ABACA7B2E0 Q37300028-1F6A8BC2-0C45-40FB-8840-8A7AA83355D5 Q37449338-6EC26E84-F990-47A3-9D7B-4449659C0E43 Q37538731-8DD6C4B9-0724-4C34-AF8E-DD9D2AD0EFAC Q37734190-1BFFBAB4-7ED7-4B77-852E-F6ABE23FC690 Q37766546-DB0647A9-9E83-4B3E-B37E-86710B2F98CE Q37827492-8F88E4D8-CCAB-48ED-8FB0-E24764AC0C04 Q37863539-A0DB2DA2-282A-41C2-B9EC-40C883DECAF8 Q37892572-4B83FB40-7D7B-4CAB-B578-79F6289CD6DF Q37947148-E09780BE-8D7B-40FC-AC90-CDDFD7A22866 Q38236876-CEBA29F0-733D-44B3-B3D4-A51A4BC95582 Q38324277-F8103BF9-E826-4C2C-9B41-7B494CBB8715 Q38419200-8BF5C85F-3ACC-473C-88DE-BF10297CB0D2 Q39034301-2B7E4CCA-E9EA-4150-9F1B-BD86A2C6AB61 Q39410889-DEEAB45B-F073-4FFD-83DA-B4DA87D76D68 Q40069164-53AA3377-224E-40AC-B81E-E3B6C641369B Q41390489-D869DB5F-A54B-4B5D-8464-686B0D33281C Q47199965-5C3ECBCB-4EC9-4A52-A131-8B89EF69ECF6

P2860

Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study.

http://www.wikidata.org/entity/Q47701176

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Doxorubicin-eluting bead-enhan ...... inoma: a pilot clinical study.

@en

Doxorubicin-eluting bead-enhan ...... inoma: a pilot clinical study.

@nl

type

label

Doxorubicin-eluting bead-enhan ...... inoma: a pilot clinical study.

@en

Doxorubicin-eluting bead-enhan ...... inoma: a pilot clinical study.

@nl

prefLabel

Doxorubicin-eluting bead-enhan ...... inoma: a pilot clinical study.

@en

Doxorubicin-eluting bead-enhan ...... inoma: a pilot clinical study.

@nl

P1433

Q47701176-679B7DDD-EEB4-439C-8ED4-F88A67B662D1

P1476

Q47701176-3E26784A-1E0A-4171-B52D-B1AB3FFCFC6F

P2093

Q47701176-0BDF7CA3-E27B-4ADB-914A-6AD4B424D669

Q47701176-3137FE92-08F7-407D-8B99-F87BD6C0AC1A

Q47701176-57C5BA31-9504-49E5-8A3D-8EE1F8C7FBFC

Q47701176-82B97226-9586-4B51-BBE8-AB24360DEBDC

Q47701176-83CB5C17-70A8-4C7F-B627-A20E55839AEC

Q47701176-A910BC0E-9C71-4453-A591-AECF612A3D74

Q47701176-AC8AA32C-28BD-416D-AAB1-03AE5405FFE9

Q47701176-C711598C-F0C2-4E6A-BD2D-F52B734E533D

Q47701176-E90ED9C5-99CD-44B7-B8DE-09191B8B32B0

P304

Q47701176-40990E79-895E-4E36-B3F5-D33EA6657CFE

P31

Q47701176-F5A2B00E-62DF-4718-A4D5-502B4959B897

P356

Q47701176-9389CDD4-7177-4DBC-BB9A-4359C27A50C3

P433

Q47701176-5BBAC93F-A068-4464-B5C8-5BFC1867B962

P478

Q47701176-9709BDC3-40F5-4DCB-9702-27BDC44A9A15

P50

Q47701176-2948F5BB-D4E1-4E97-928D-4FFC929E8A17

Q47701176-4D9E942F-00F9-4E2A-A177-5A30ED453729

Q47701176-67CABF56-FECC-4000-A95B-5483795382CD

Q47701176-AF2B2BC1-081F-41D0-AD5D-2D8C913C8C36

P577

Q47701176-B584E81B-1314-48AB-A4FB-E79B23924404

P5875

Q47701176-064F0330-758C-4330-BA60-66B312167BBB

P698

Q47701176-5C9263F1-84BF-4B05-AF97-6EF8048BADC5

P356

J.JHEP.2008.03.021

P1433

Journal of Hepatology

P1476

Doxorubicin-eluting bead-enhan ...... cinoma: a pilot clinical study

@en

P2093

Carlo Bartolozzi

http://www.w3.org/2001/XMLSchema#string

Claudio Vignali

http://www.w3.org/2001/XMLSchema#string

Clotilde Della Pina

http://www.w3.org/2001/XMLSchema#string

Dania Cioni

http://www.w3.org/2001/XMLSchema#string

Elena Bozzi

http://www.w3.org/2001/XMLSchema#string

Franco Filipponi

http://www.w3.org/2001/XMLSchema#string

Paolo De Simone

http://www.w3.org/2001/XMLSchema#string

Pasquale Petruzzi

http://www.w3.org/2001/XMLSchema#string

Riccardo Lencioni

http://www.w3.org/2001/XMLSchema#string

P304

217-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JHEP.2008.03.021

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Irene Bargellini

Maurizia R Brunetto

P577

2008-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5364811

http://www.w3.org/2001/XMLSchema#string

P698

18486261

http://www.w3.org/2001/XMLSchema#string